A New Vaccine for Mycobacterium avium Subspecies paratuberculosis
Author Information
Author(s): Gilbert Sarah C., Sridhar Saranya, Linedale Richard, Dierkes Nicola, Sidi-Boumedine Karim, Hermon-Taylor John
Primary Institution: St George's University of London
Hypothesis
Can a novel multi-antigen vaccine effectively immunize against Mycobacterium avium subspecies paratuberculosis?
Conclusion
The new vaccine was highly immunogenic and effectively reduced existing infections in mice without causing adverse effects.
Supporting Evidence
- The vaccine showed significant immune responses in vaccinated mice.
- Vaccination significantly reduced the load of Mycobacterium avium subspecies paratuberculosis in spleen and liver.
- No adverse effects were observed in any of the vaccinated mice.
Takeaway
Scientists created a new vaccine to help protect against a germ that can make animals and people sick, and it worked well in mice without making them sick.
Methodology
The vaccine was tested on C57BL/6 mice using DNA-prime/MVA-boost and Ad5-prime/MVA-boost protocols.
Limitations
The study was conducted in mice, and further research is needed in naturally infected animals and humans.
Participant Demographics
C57BL/6 mice, 4-6 weeks old, female.
Statistical Information
P-Value
p=0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website